Patients’, caregivers and clinicians’ perspectives on education and support about methotrexate: survey to 26 European Countries
ARP Rheumatology · 2025
DOI: 10.63032/fuwk2508 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARP Rheumatology, 2025. Verfasst von Cristiano Matos und 24 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Politécnico de Coimbra. Hauptthemen laut MEDLINE: Methotrexate, Antirheumatic Agents, Caregivers, Patient Education as Topic.
Abstract (Originalsprache)
OBJECTIVES: To assess patients', carers', nurses' and physicians' perspectives and experiences regarding patient education (PE) and support of Methotrexate (MTX) treatment in Europe. METHODS: An international team of researchers and clinicians, including rheumatology nurses, a pharmacist, a rheumatologist, and three patient representatives, developed a survey. Common and sample-specific questions were conceived for adult patients or carers (≥18 years) of children/young people with RMDs, nurses, and physicians working in rheumatology practice in Europe. The survey was available in English and, for patients/carers, in eight additional languages, disseminated between May 2022 and May 2023. Ethics committee approval was obtained (116_CEIPC/2022_IPC). RESULTS: A total of 1526 patients, 145 carers, 354 nurses, and 291 physicians (96% rheumatologists), from 26 European countries participated. Only 28% of patients had a PE with nurse when starting oral MTX, with a slight increase to 42% for the subcutaneous form, with variations across Europe (Northern=69%, Eastern=52%, Western=50%, Southern=23%). Patients' perspectives align with physicians, whereas nurses reported higher access rates. Around 77% of patients had/have concerns about side effects, which were discussed with health professionals in 69% of the cases, though 46% of these concerns remained unresolved. The priority ranking of topics to be addressed in PE was similar overall for the three subgroups. CONCLUSION: PE and support regarding MTX are unequal across Europe and can be improved by offering opportunities to clarify concerns through more access to nursing consultations. There is an overall agreement between patients and clinicians regarding key areas of education, although a tailored approach is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto Politécnico de Coimbra.
- Great Ormond Street Children's Hospital NHS Foundation Trust.
- Rey Juan Carlos University.
- University of Florence.
- Zurich University Hospital.
- University of Pécs.
Zitieren
APA
Matos, C., Livermore, P., Ortiz-Piña, M., El Aoufy, K., Buerki, K., Ágoston-Szabó, A., Batšinskaja, D., Melicharová, J., Karlsson, M. L., Claes, K., Rodriguez Vargas, A. I., Moholt, E., Ludvigsen, A., Martin, U., Erstling, U., Camon, A., Pais, A., Konstantinou, M., Nikoloudaki, M., …, & Ferreira, R. J. O. (2025). Patients’, caregivers and clinicians’ perspectives on education and support about methotrexate: survey to 26 European Countries. ARP Rheumatology. https://doi.org/10.63032/fuwk2508
Vancouver
Matos C, Livermore P, Ortiz-Piña M, El Aoufy K, Buerki K, Ágoston-Szabó A, et al. Patients’, caregivers and clinicians’ perspectives on education and support about methotrexate: survey to 26 European Countries. ARP Rheumatology. 2025. doi:10.63032/fuwk2508
BibTeX
@article{Matos2025,
author = {Matos, Cristiano and Livermore, Polly and Ortiz-Piña, Mariana and El Aoufy, Khadija and Buerki, Kristina and Ágoston-Szabó, Agnes and Batšinskaja, Darja and Melicharová, Jana and Karlsson, Marie-Louise and Claes, Karlien and Rodriguez Vargas, Ana Isabel and Moholt, Ellen and Ludvigsen, Ane and Martin, Una and Erstling, Ulrike and Camon, Angela and Pais, Ana and Konstantinou, Mikaella and Nikoloudaki, Myrto and Makri, Souzi and Silva, Bruno and Paiva, Cláudia and Nikiphorou, Elena and Marques, Andrea and Ferreira, Ricardo J O},
title = {Patients’, caregivers and clinicians’ perspectives on education and support about methotrexate: survey to 26 European Countries},
journal = {ARP Rheumatology},
year = {2025},
doi = {10.63032/fuwk2508}
}
EUVIMED